肌脂肪变性(肌内脂肪浸润)与肾移植术后不良生存相关:一项大型回顾性队列验证
研究基于1598名健康本地人群的腹部CT建立肌少症和肌脂肪变性的诊断阈值,并在992例肾移植受者中验证其预后价值。多因素分析显示肌脂肪变性是全因死亡的独立基线危险因素(校正HR=3.08,P=0.022),而肌少症与预后无关,两者均与移植物丢失无关。
要点
- 基于CT第三腰椎中部腹肌测量建立的肌脂肪变性阈值,在肾移植受者中与全因死亡独立相关(校正HR=3.08,P=0.022)。
- 肌少症在肾移植受者中与全因死亡及移植物丢失均无显著关联。
- 肌脂肪变性和肌少症均不是移植物丢失的独立危险因素。
核心结论
- 肌脂肪变性是肾移植术后死亡的独立危险因素,而肌少症不是;两者均与移植物丢失无关。
研究设计与样本
- 回顾性队列研究,纳入1598名健康本地人群(2010–2022年腹部CT)建立阈值,并纳入992例本中心肾移植受者(2015–2019年),基于第三腰椎中部CT图像计算骨骼肌指数和肌肉衰减值。
诊断标准与关键数值
- 基于1598名健康本地人群建立年龄和性别特异性肌少症与肌脂肪变性诊断阈值;992例受者中肌少症33例(3.3%),肌脂肪变性95例(9.5%)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: We aim to establish diagnostic thresholds of sarcopenia and myosteatosis based on CT measurements, and to validate their prognostic value in a large cohort of kidney transplant recipients.
METHODS: Local healthy population with abdominal CT between 2010 and 2022, and patients underwent kidney transplantation between 2015 and 2019 at our center were retrospectively included. The skeletal muscle index and muscle attenuation of abdominal muscles were calculated based on CT image at the middle of the third lumbar vertebra. Primary endpoints included all-cause mortality and death censored allograft survival.
RESULTS: Age- and sex-specific thresholds for sarcopenia and myosteatosis were established based on 1598 healthy local population. The final patient cohort consisted of 992 kidney transplant recipients (median age 34 years, interquartile range 28-44 years; 694 males), including 33 (3.3%) with sarcopenia and 95 (9.5%) with myosteatosis. Multivariate analysis revealed myosteatosis (adjusted hazard ratio = 3.08, p = 0.022) was an independent baseline risk factor of mortality after adjusting for age, the history of cancer, and the history of cardiovascular event. Multivariate analysis found preemptive transplantation (adjusted hazard ratio = 0.36, p = 0.037) was an independent protective factor of allograft loss. No difference was found in the prognosis between kidney transplant recipients with and without sarcopenia.
CONCLUSION: Myosteatosis was an independent risk factor of mortality after kidney transplantation, but sarcopenia was not. Neither sarcopenia nor myosteatosis was associated with graft loss.
引用
- Chen J, Li Y, Li C, et al. Myosteatosis is associated with poor survival after kidney transplantation: a large retrospective cohort validation. Abdom Radiol (NY). 2024. PMID: 38326665. doi:10.1007/s00261-023-04180-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。